Inherited Breast Carcinoma: Prospective findings in 1 194 women at risk

Authors

  • Pål Møller Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Lovise Maehle Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Ketil Heimdal Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Anne Dørum Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Steinar Tretli Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Per Helgerud Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Hanne Quist Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Hilde Bjørndal Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Rolf Kåresen Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Arne Nysted Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Jan E. Varhaug Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Hans E. Fjøsne Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Roald J. Guleng Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Jan Due Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Per Bøhler Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Karl Erik Giercksky Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Claes Tropé Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø
  • Stener Kvinnsland Unit of Medical Genetics, Department of Oncology, Surgical Department, Department of Radiology, Department of Pathology, Department of Gynecology, The Norwegian Radium Hospital, Oslo; The Cancer Registry of Norway, Oslo; Surgical Department, Ullevål Hospital, Oslo; Surgical Department, Rogaland Central Hospital, Stavanger; Surgical Department, Haukeland University Hospital, Bergen; Surgical Department, The Regional Hospital, Trondheim; Surgical Department, Nordland Central Hospital, Bodø

DOI:

https://doi.org/10.3109/02841869609098515

Abstract

According to preset criteria, 1194 women at risk for inherited breast carcinoma were selected and subjected to examination. Six hundred and three women were examined once, 591 were followed for a mean of 1.8 years. Twenty infiltrating cancers (median age 49 years) and 16 precancers (median age 44 years) were found, demonstrating that breast carcinoma continued to occur in the selected families as expected under the hypothesis of dominant inheritance. At first round, 14 (1.2%) infiltrating carcinomas and a total of 22 (1.8%) cancers or precancers were found. Incidence rates of 0.58% pr. year for infiltrating cancers, and 1.04% pr. year for cancer or precancer were calculated. This confirms the tentative conclusions that were drawn in our previous report. These are the first prospective reports documenting how to delineate a high risk group for premenopausal breast cancer, and how to diagnose cancer at an early stage. All but two affected women had cancer without lymph node metastasis. Although a longer observation time is needed, we cautiously conclude that the results are in keeping with our aim of providing safety for those at risk. Clinical use of predictive genetic testing may be implemented within these families.

Downloads

Download data is not yet available.

Downloads

Published

1996-01-01

How to Cite

Møller, P. ., Maehle, L. ., Heimdal, K. ., Dørum, A. ., Tretli, S. ., Helgerud, P. ., … Kvinnsland , S. . (1996). Inherited Breast Carcinoma: Prospective findings in 1 194 women at risk. Acta Oncologica, 35(Supp 8), 7–11. https://doi.org/10.3109/02841869609098515

Issue

Vol. 35 No. Supp 8 (1996): Acta Oncologica

Section

Articles